Add to ORKGThis article will use the NIH patent controversy as a focal point for considering when the results of government-sponsored research should be patented and when they should be dedicated to the public domain. First, this article will review the recent history of federal government policy on patenting the results of government-sponsored research. Next, this article will highlight some of the complexities involved in achieving technology transfer from the public sector to the private sector that current policy may oversimplify. With this background, this article will return to a more detailed analysis of the NIH cDNA patenting controversy and consider the lessons it may hold for technology transfer policy generally
Mr. Harnett argues that emphasizing technology transfer at institutions such as the National Institu...
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Controversy over intellectual property rights in the results of large-scale cDNA sequencing raises i...
This article will use the NIH patent controversy as a focal point for considering when the results o...
The government\u27s pro-patent policy may not be the best way to promote technological advances. Thi...
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be paten...
This Comment will address the conflict between the U.S. patent laws and biotechnology by focusing on...
Federal policy since 1980 has reflected an increasingly confident presumption that patenting discove...
The increasing promise of federal funding for mapping and sequencing the human genome has brought wi...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
Patents on human genetic information have been controversial among different groups for different re...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
This article revisits the logical and empirical basis for current government patent policy in order ...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
Mr. Harnett argues that emphasizing technology transfer at institutions such as the National Institu...
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Controversy over intellectual property rights in the results of large-scale cDNA sequencing raises i...
This article will use the NIH patent controversy as a focal point for considering when the results o...
The government\u27s pro-patent policy may not be the best way to promote technological advances. Thi...
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be paten...
This Comment will address the conflict between the U.S. patent laws and biotechnology by focusing on...
Federal policy since 1980 has reflected an increasingly confident presumption that patenting discove...
The increasing promise of federal funding for mapping and sequencing the human genome has brought wi...
The various research efforts that comprise the Human Genome Project will inevitably both draw on and...
Patents on human genetic information have been controversial among different groups for different re...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
This article revisits the logical and empirical basis for current government patent policy in order ...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
Mr. Harnett argues that emphasizing technology transfer at institutions such as the National Institu...
As nearly everyone in biotechnology knows by now, the U.S. Government\u27s application for a patent ...
Controversy over intellectual property rights in the results of large-scale cDNA sequencing raises i...